Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: three year results from a phase 3 study (SPIRIT-P1)

Chandran, V, Fleischmann, R, Lespessailles, E et al. (4 more authors) (2018) Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: three year results from a phase 3 study (SPIRIT-P1). In: Acta Dermato-Venereologica. 5th World Psoriasis & Psoriatic Arthritis Conference, 27-30 Jun 2018, Stockholm, Sweden. Society for Publication of Acta Dermato-Venereologica , pp. 23-24.

Metadata

Authors/Creators:
  • Chandran, V
  • Fleischmann, R
  • Lespessailles, E
  • Helliwell, P
  • Benichou, O
  • Erickson, J
  • Shuler, C
Dates:
  • Published: 14 June 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Sep 2018 14:41
Last Modified: 07 Sep 2018 08:56
Status: Published
Publisher: Society for Publication of Acta Dermato-Venereologica
Identification Number: https://doi.org/10.2340/00015555-2978
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics